Short CommunicationTopical nitric oxide releasing nanoparticles are effective in a murine model of dermal Trichophyton rubrum dermatophytosis
Graphical Abstract
Systemic therapies are preferred for treating dermal dermatophytosis due to inadequate penetration of topical agents. However, systemic antifungals are associated with off-target effects, lengthy treatment schedules and limited tissue penetration. This study investigated topical nitric oxide releasing nanoparticles (NO-np) in a murine model of dermal dermatophyosis. Nitric oxide provides broad-spectrum multi-mechanistic antimicrobial activity while the small size of nanoparticles offers enhanced penetration and permeation of tissues. Data demonstrated NO-np inhibition of Trichophyton rubrum in vitro, as well as in mice. NO-np also decreased tissue IL-2, 6, 10 and TNFα, indicating earlier attenuation of the host inflammatory response.
Section snippets
Methods
NO-np were synthesized as previously described.6 Minimum inhibitory concentrations (MICs) were determined for two T. rubrum reference strains (ATCC MYA-4438 and ATCC 28189) and a clinical isolate using methods proposed by the Clinical and Laboratory Standards Institute (CLSI), modified by the use of a resazurin colorimetric assay.14 Minimum fungicidal concentrations (MFCs) were determined as previously described.15 Additionally, antimicrobial effects of the MIC of NO-np were visualized directly
Results
The MICs of NO-np for the T. rubrum reference strains and clinical isolate were 10 and 5 mg/mL, respectively. MFC results demonstrated fungistatic behavior of NO-np, and empty nanoparticles did not demonstrate antifungal activity at concentrations up to 20 mg/mL (Figure 1, A). On TEM, accumulation of material suggestive of intracellular vesicles and black granules within vacuoles was observed in the fungal cells following incubation with the MIC of NO-np (Figure 1, B).
CFU quantification
Discussion
Our results present topical NO-np as a potential treatment for dermal T. rubrum infection. NO exerts direct fungistatic activity via DNA damage, lipid peroxidation, and enzyme inactivation,3 as well as indirect activity via upregulation of macrophage phagocytic activity.17 Of note, NO-np exhibit trans-nitrosylation activity in addition to NO release, which likely explains the significant effects visualized on TEM.18
In addition to fungal death, NO-np were associated with decreased IL-2, 6, 10
Acknowledgments
We thank Dr. Mahmoud A. Ghannoum of Case Western Reserve University for providing the T. rubrum ATCC MYA-4438 strain.
References (23)
- et al.
Nitric oxide–releasing nanoparticles prevent Propionibacterium acnes–induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response
J Invest Dermatol
(2015) - et al.
Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites
Nitric Oxide
(2008) - et al.
Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy
J Sex Med
(2014) - et al.
Sustained release nitric oxide from long-lived circulating nanoparticles
Free Radic Biol Med
(2010) - et al.
Effect of nitric oxide on phagocytic activity of lipopolysaccharide-induced macrophages: possible role of exogenous L-arginine
Cell Biol Int
(2007) - et al.
Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione
Nitric Oxide
(2011) - et al.
Stimulation, inhibition and death of macrophages infected with Trichophyton rubrum
Microbes Infect
(2006) - et al.
Update in antifungal therapy of dermatophytosis
Mycopathologia
(2008) - et al.
Topical delivery of drugs for the effective treatment of fungal infections of skin
Curr Pharm Des
(2015) - et al.
NO inhibitions: antimicrobial properties of nitric oxide
Clin Infect Dis
(1995)
Nitric oxide releasing nanoparticle synthesis and characterization
Methods Mol Biol
Cited by (17)
NO donors as the wonder molecules with therapeutic potential: Recent trends and future perspectives
2023, Coordination Chemistry ReviewsPotent application of nitric oxide-releasing nanomaterials against toxigenic fungi and their mycotoxins
2019, Nanomycotoxicology: Treating Mycotoxins in the Nano Way
Funding: CBCO received fellowship funding from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (process number: 99999.007910/2014-02) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (process number: 150261/2016-0).
Disclosures: AJF and JMF are co-inventors of NO-np, a technology licensed to Nano Biomed Inc. for commercialization. JDN serves as an advisor to Nano Biomed Inc. Portions of this publication were presented in abstract form at the 74th Annual Meeting of the American Academy of Dermatology.
- 1
These authors contributed equally to the production of this work.